Editorial
Pharmacological approaches to reducing allogeneic blood exposure
Nucleic acid technology screening of Australian blood donors for hepatitis C and human immunodeficiency virus-1 RNA
Collaborative study to calibrate hepatitis C virus genotypes 2–6 against the HCV International Standard, 96/90 (genotype 1)
The influence of platelet additive solutions on cytokine levels and complement activation in platelet concentrates during storage
Inactivation of viral and prion pathogens by γ-irradiation under conditions that maintain the integrity of human albumin
Efficacy, tolerability, safety and pharmacokinetics of a nanofiltered intravenous immunoglobulin
Large-scale production and properties of human plasma-derived activated Factor VII concentrate
Cost-effectiveness of leucocyte depletion of red-cell transfusions for patients undergoing cardiac surgery
Lymphocyte T subsets and natural killer cells in Italian and Philippino blood donors
Detection of platelet-reactive antibodies in patients who are refractory to platelet transfusions, and the selection of compatible donors
Detection of platelet-reactive antibodies in patients who are refractory to platelet transfusions, and the selection of compatible donors
Detection of platelet-reactive antibodies in patients who are refractory to platelet transfusions, and the selection of compatible donors
Detection of platelet-reactive antibodies in patients who are refractory to platelet transfusions, and the selection of compatible donors
Detection of platelet-reactive antibodies in patients who are refractory to platelet transfusions, and the selection of compatible donors
Detection of platelet-reactive antibodies in patients who are refractory to platelet transfusions, and the selection of compatible donors
Detection of platelet-reactive antibodies in patients who are refractory to platelet transfusions, and the selection of compatible donors
Detection of platelet-reactive antibodies in patients who are refractory to platelet transfusions, and the selection of compatible donors
Detection of platelet-reactive antibodies in patients who are refractory to platelet transfusions, and the selection of compatible donors
Detection of platelet-reactive antibodies in patients who are refractory to platelet transfusions, and the selection of compatible donors
Detection of platelet-reactive antibodies in patients who are refractory to platelet transfusions, and the selection of compatible donors
Detection of platelet-reactive antibodies in patients who are refractory to platelet transfusions, and the selection of compatible donors
Diary of events